This talk is from the 2022 Advancing Excellence in Transgender Health Care Conference.
Learning Resources — Pre-Exposure Prophylaxis (PrEP)
In this interactive webinar, participants will learn about novel approaches to HIV prevention and care, including status-neutral care paradigms, same-day pre-exposure prophylaxis (PrEP), and rapid antiretroviral start programs. The webinar will also provide up-to-date information about how to implement long-acting injectable PrEP at health centers.
Long-acting injectable cabotegravir was approved for HIV pre-exposure prophylaxis in late 2021. In this interactive webinar, participants will learn about the effectiveness, advantages, and disadvantages of long-acting injectable cabotegravir as well as the clinical and programmatic steps to incorporate it into practice.
HIV prevention with pre-exposure prophylaxis (PrEP) is highly effective and a component of the Ending the HIV Epidemic in the U.S. initiative, yet use is not commensurate with need. Training and technical assistance is available for health centers to start or scale up PrEP programs. In this webinar, participants will become familiar with PrEP resources and hear how health centers have implemented programming to improve HIV prevention and expand access to PrEP.
Many sexual and gender minority people eligible for or taking HIV pre-exposure prophylaxis (PrEP) are at risk for sexually transmitted infections (STIs) and testing and treating STIs are key aspects of providing PrEP. In this clinically focused, case-based webinar, Dr. Kevin Ard will describe important updates in STI management for PrEP patients, based on the 2021 STI Treatment Guidelines from CDC.
In this talk from the 2021 Advancing Excellence in Transgender Health conference, Dr. Poteat reviews data on PrEP among transgender people, outlines current guidelines for PrEP use, and describes gender-affirming practices for PrEP implementation.
This module reviews current methods and recommendations for HIV testing, prevention, and treatment for LGBTQIA+ people, including information on pre-exposure prophylaxis (PrEP) for HIV prevention.
This publication discusses the advantages and challenges of telePrEP, the use of telemedicine specifically for pre-exposure prophylaxis (PrEP), and provides best practices for clinicians and PrEP programs.
Participants of this training will learn about the current research in telehealth and PrEP/HIV care outcomes, including PrEP @ Home and considerations for the administration and management of PrEP during COVID-19. Additionally, training participants will explore the topic of PrEP program implementation in a health center setting, including best practices for systems of care and improving adherence.